RAS mutation specific survival in patients with metastatic colorectal cancer treated with trifluridine/tipiracil

被引：0
|
作者：
Grell, Peter
Batko, Stanislav
Pirsthuk, Alina
Borilova, Simona
Polachova, Katerina
Mazuchova, Blanka
Tomasek, Jiri
Fabian, Pavel
Berkovcova, Jitka
Bardelcik, Miroslav
Obermannova, Radka
Buchler, Tomas
Kiss, Igor
机构：
[1] Masaryk Mem Canc Inst, Brno, Czech Republic
[2] Motol Univ Hosp, Prague, Czech Republic
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 3_SUPPL期
关键词：
613-135-2370-7650-2700; 3282-206-4957-326-5009-5024-5025; 3282-206-4957-326-5009-2386; 10; 2; 38092-25821; 38092-18412; 38092-18849; 8; 4;
D O I：
10.1200/JCO.2024.42.3_suppl.197
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Detection of trifluridine in tumors of patients with metastatic colorectal cancer treated with trifluridine/tipiracil
    Yoshiaki Fujimoto
    Ryota Nakanishi
    Mamoru Nukatsuka
    Kazuaki Matsuoka
    Koji Ando
    Takeshi Wakasa
    Hiroyuki Kitao
    Eiji Oki
    Yoshihiko Maehara
    Masaki Mori
    [J]. Cancer Chemotherapy and Pharmacology, 2020, 85 : 1029 - 1038
  • [2] Detection of trifluridine in tumors of patients with metastatic colorectal cancer treated with trifluridine/tipiracil
    Fujimoto, Yoshiaki
    Nakanishi, Ryota
    Nukatsuka, Mamoru
    Matsuoka, Kazuaki
    Ando, Koji
    Wakasa, Takeshi
    Kitao, Hiroyuki
    Oki, Eiji
    Maehara, Yoshihiko
    Mori, Masaki
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (06) : 1029 - 1038
  • [3] QUAlity of LIfe and survival of meTAStatic colorectal cancer patients treated with trifluridine-tipiracil (QUALITAS)
    Hamers, P.
    Vink, G.
    Elferink, M.
    Koopman, M.
    May, A. M.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S434 - S435
  • [4] Quality of Life and Survival of Metastatic Colorectal Cancer Patients Treated With Trifluridine-Tipiracil (QUALITAS)
    Hamers, Patricia A. H.
    Vink, Geraldine R.
    Elferink, Marloes A. G.
    Stellato, Rebecca K.
    Dijksterhuis, Willemieke P. M.
    Punt, Cornelis J. A.
    Koopman, Miriam
    May, Anne M.
    [J]. CLINICAL COLORECTAL CANCER, 2022, 21 (02) : 154 - 166
  • [5] Prognostic factors in refractory metastatic colorectal cancer patients treated with Trifluridine/Tipiracil
    Koper, Agnieszka
    Wilenski, Slawomir
    Sledzinska, Paulina
    Bebyn, Marek
    Koper, Krzysztof
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (12) : 10867 - 10877
  • [6] Survival analysis based on the grade of neutropenia in patients with metastatic colorectal cancer treated with trifluridine-tipiracil
    Avino Tarazona, V.
    Rodriguez Garces, M.
    Amor Urbano, M.
    Bolanos Naranjo, M.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S140 - S140
  • [7] Prognostic Value of Sarcopenia in Metastatic Colorectal Cancer Patients Treated with Trifluridine/Tipiracil
    Malik, Mateusz
    Michalak, Maciej
    Radecka, Barbara
    Gelej, Marek
    Jackowska, Aleksandra
    Filipczyk-Cisarz, Emilia
    Hetman, Katarzyna
    Foszczynska-Kloda, Malgorzata
    Kania-Zembaczynska, Beata
    Manka, Danuta
    Orlikowska, Marlena
    Rogowska-Dros, Hanna
    Bodnar, Lubomir
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (21)
  • [8] Prognostic factors in refractory metastatic colorectal cancer patients treated with Trifluridine/Tipiracil
    Agnieszka Koper
    Sławomir Wileński
    Paulina Śledzińska
    Marek Bebyn
    Krzysztof Koper
    [J]. Journal of Cancer Research and Clinical Oncology, 2023, 149 : 10867 - 10877
  • [9] Safety and efficacy of trifluridine/tipiracil plus bevacizumab in RAS mutated patients with metastatic colorectal cancer
    Michalaki, Vasiliki
    Theodosopoulos, Thedosios
    Vezakis, Antonios
    Papaconstantinou, Ioannis
    Kontis, Ioannis
    Dafnios, Nikolaos
    Frangoulidis, George
    Karandrea, Despina
    Papadimitriou, Christos
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] Trifluridine/Tipiracil: A Review in Metastatic Colorectal Cancer
    Celeste B. Burness
    Sean T. Duggan
    [J]. Drugs, 2016, 76 : 1393 - 1402
12345